Emad Abu-Assi

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

Triglycerides and Residual Atherosclerotic Risk

“Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”